Croton Tiglium

Croton tiglium  Linn.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Euphorbiaceae.
Habitat Native to South-East Asia. Now cultivated in Assam, Bengal and South India.
English Purging Croton.
Ayurvedic Jayapaala, Dravanti, Dantibija, Tintidiphala.
Unani Habb-us-Salaateen, Jamaalgotaa, Hubb-ul-Malook.
Siddha / Tamil Nervaalam.
Action Cathartic, rubefacient, irritant. Used in ascites, anasarca, dropsy and enlargement of abdominal viscera.
Dosage Seed—6–12 mg powder. (API Vol. IV.)
Taxonomic Cohort Genus Croton (2 documented species); Family Euphorbiaceae (50 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Croton tiglium (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Euphorbiaceae (primary family classification: Euphorbiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Native to South-East Asia. Now cultivated in Assam, Bengal and South India.

Across classical and vernacular Indian systems of medicine, Croton tiglium is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Purging Croton; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Jayapaala, Dravanti, Dantibija, Tintidiphala; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Habb-us-Salaateen, Jamaalgotaa, Hubb-ul-Malook; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Nervaalam. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Croton tiglium are: Cathartic, rubefacient, irritant. Used in ascites, anasarca, dropsy and enlargement of abdominal viscera. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Croton tiglium establish the following evidence base: The seed oil is purgative. It produces severe symptoms of toxicity when taken internally or applied externally to the skin. Croton oil showed tumour-promoting activity on mouse skin. The skin irritant and tumour promoting diterpene esters of the tigliane type (phorbol esters) and toxins have been isolated from the seeds. (In China, where the herb is employed for the treatment of gastro-intestinal disturbances, the highest incidence of nasopharyngeal cancer has been reported.) 1 ml oil is usually fatal. Phorbols (terpenoids) from nonvolatile oil are toxic. Crotin, a toxic albuminous substance, is not extracted in the oil. The plant caused haematuria and swelling of lymph glands in animals.

In specialized pharmacognostic classifications, Croton tiglium is also represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

image1

Figure 1: Authenticated crude herb specimen — Croton tiglium seed.

image3

Botanical Reference 1: Croton tiglium — Botanical specimen

image4

Botanical Reference 2: Croton tiglium — Botanical specimen

image5

Botanical Reference 3: Croton tiglium — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Croton comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Croton oblongifolius (Action: Same as that of C. tiglium). Comparing Croton tiglium alongside its congeners in genus Croton highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Euphorbiaceae encompasses 50 documented medicinal species (2.76% of the 1,814-species flora). Other representative medicinal members of Euphorbiaceae include: Acalypha ciliata (Kuppi), Acalypha fruticosa (Birch-leaved Acalypha), Acalypha indica (Kuppi), Aleurities moluccana (Akshota), Baliospermum montanum (Danti). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image2

Figure 2: Quantitative documentation profile across all 50 medicinal species of family Euphorbiaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

For clinical and traditional dispensing, the standardized posology and crude herb dosage for Croton tiglium are prescribed as follows: Seed—6–12 mg powder. (API Vol. IV.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Croton tiglium integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top